Radiotherapy and Temozolomide for Newly Diagnosed Glioblastoma: Recursive Partitioning Analysis of the EORTC 26981/22981-NCIC CE3 Phase III Randomized Trial - Concepedia

Concepedia

Publication | Closed Access

Radiotherapy and Temozolomide for Newly Diagnosed Glioblastoma: Recursive Partitioning Analysis of the EORTC 26981/22981-NCIC CE3 Phase III Randomized Trial

505

Citations

20

References

2006

Year

René-Olivier Mirimanoff, Thierry Gorlia, Warren Mason, Martin J. van den Bent, Rolf‐Dieter Kortmann, Barbara Fisher, Michele Reni, Alba A. Brandes, J. Curschmann, S. Villà,

Journal of Clinical Oncology

Abstract

RPA retains its prognostic significance overall as well as in patients receiving RT with or without TMZ for newly diagnosed GBM, particularly in classes III and IV.

References

	Year	Citations

Page 1